Stingfree AB's PROTEX® white snus technology validated in groundbreaking oral health study

Stingfree AB is proud to announce the publication of a peer-reviewed pilot study confirming the oral health benefits of the company's proprietary PROTEX® nicotine pouch technology. The study, published in Acta Odontologica Scandinavica, shows a significant reduction in oral lesions and gum irritation after five weeks of using the Stingfree Strong Blue Mint nicotine pouch, which features PROTEX® technology's innovative protective barrier.

The study, led by researchers at the University of Catania and involving 23 Swedish dentists who regularly use snus or nicotine pouches, is the first of its kind to evaluate the self-reported oral health effects of a product designed to reduce oral mucosal irritation. The study showed, among other things, a 27.3 % reduction in snus-related lesions, a complete elimination of self-reported cases of gingivitis, and a 90 % reduction in gum irritation. No participant experienced worsening lesions, and no cases remained in the most severe snuff lesion category after the end of the study.

Stingfree's PROTEX® technology consists of an impermeable barrier designed to protect the gums from direct contact with nicotine and the pouch contents, while maintaining the user's sensory experience and nicotine release. This technology addresses one of the most common problems among oral nicotine pouch users: local irritation and the development of mucosal lesions.

”We are extremely pleased to have clinical confirmation of our technology in a group of dentists. This study marks an important step in our efforts to reduce harm and improve user comfort in the nicotine pouch category.”
- Daniel Wiberg, CEO, Stingfree AB

The study provides strong evidence for the role of the PROTEX® pouch in reducing oral health problems often associated with snus and nicotine pouch use.

The full study is available online at Acta Odontologica Scandinavica and National Library of Medicine (PubMed®).